Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 22 Sarcoma 8 Uterine Cervical Neoplasms 7 Breast Neoplasms 6 Rectal Neoplasms 5 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Colonic Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Sarcoma, Synovial 2 Neurofibrosarcoma 2 Liver Neoplasms 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1

Interventions

Tranexamic Acid 13 Sodium Chloride 4 Misoprostol 4 Saline Solution 3 Enoxaparin 3 carbetocin 2 Tourniquets 2 Ringer's Lactate 2 Oxytocin 2 Endoscopic Mucosal Resection 2 Dalteparin 2 Aspirin 2 maleimide-polyethylene glycol-modified hemoglobin, MP4 1 bemiparin 1 Vitamin B 6 1 Vasopressins 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Ultrasonography 1 Tinzaparin 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Sutures 1 Surveys and Questionnaires 1 Surgicel 1 Standard of Care 1 Solutions 1 Sensitivity Training Groups 1 Rivaroxaban 1 Ringer's Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemorrhage × Diathermy × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡